Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

Medications can cause eye problems, so regular eye check-ups are important.

New treatments for lupus show promise, but more research is needed, especially for children.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Anti-CD19 therapy may help treat SLE and NMOSD.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Alopecia areata treatment varies, with no optimal method established yet.

Clobetasol propionate ointment can help some people with total hair loss regrow hair.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

DPCP is effective for treating severe alopecia areata, but relapse is common.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

The conclusion is that it's important to tell apart alopecia areata from lipedematous alopecia for proper treatment, as alopecia areata can be reversed.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.